Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label follow-up study of levetiracetam in pediatric partial onset seizures
2004-000200-40Phase 3Completed
- Sponsor
- UCB
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of levetiracetam in Focal Onset Epilepsy, sponsored by UCB. Primary endpoints: Long-term safety of adjunctive levetiracetam and Long-term efficacy of adjunctive levetiracetam. Started Nov 2004; status: completed.
02
Drugs
levetiracetam
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on 2004-000200-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000200-40.